The government is considering increasing the prices of a wide range of medicines—from life-saving drugs used to treat cancer to routine antibiotics and injections—by 10 to 20 percent. Due to ongoing tensions in West Asia, the cost of producing medicines has suddenly increased; As a result, the government may be forced to take this drastic step to ensure continuity of supply.
Impact of Gulf crisis on medical bills
In fact, the process of producing drugs uses a special class of chemicals called “solvents”. These solvents—which are vital for dissolving and purifying pharmaceutical compounds—are directly linked to the supply chains of crude oil and gas, the main sources of which are in the Gulf region. There is a severe shortage of these chemicals due to the ongoing turmoil in that region. Although these chemicals are not part of the final drug product, the entire production process cannot be completed without them. Additionally, due to safety reasons, pharmaceutical companies are unable to store these chemicals in large quantities. As a result, if this crisis continues for the next two to three months, there may be a shortage of many essential medicines in the market.
Will drug prices rise forever?
It is a matter of relief that the government does not intend to increase the prices of medicines forever. According to sources, this is being done only as a short-term or temporary arrangement. The government is currently working on a proposal under which this 10-20 percent increase in prices will be implemented for at least three months. As global supply chains normalize and the movement of these chemicals resumes, drug prices will return to their previous levels. Authorities have made it clear that while they are committed to supporting the pharmaceutical industry, consumers will not be burdened with increased prices in the long run.
Drug companies: compulsion or race to make profits?
Key industry organisations, such as the Indian Pharmaceutical Alliance (IPA) and Organization of Pharmaceutical Producers of India (OPPI) have already expressed their concerns to the government. Drug companies argue that they can no longer bear the burden of this huge increase in production costs, as their profit margins have already shrunk. They say that if they do not get any relief in terms of prices, the production of some essential medicines will become economically unviable, due to which they may have to stop production. Although a section of the industry had demanded a price increase of up to 50 per cent, the government has made it clear that under no circumstances will it allow an increase beyond a fixed (balanced) limit of 10 to 20 per cent.
Old vs New Stock Conundrum
There is also a technical problem involved in this entire process. If medicines are manufactured at higher costs during this period of crisis, then at what rate will companies be allowed to sell the remaining stock when the situation becomes normal? At present, the government is seriously considering this particular aspect also. To ease price increases of these essential medicines—which are normally subject to price control regulations—the Government may use special provisions applicable in exceptional circumstances in the public interest.
The ongoing internal discussions within the government are expected to be completed soon, after which an official notification is likely to be issued. The main objective of the government is to protect the interests of the general public, and also to ensure that there is no shortage of essential medicines in the market.
